Details of the Drug

General Information of Drug (ID: DMG3WBJ)

Drug Name
YH012
Indication
Disease Entry ICD 11 Status REF
Aggressive cancer 2A00-2F9Z Investigative [1]
Drug Type
Bispecific antibody-drug conjugate
Cross-matching ID
PubChem CID
5270904
TTD ID
DKHL40

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Erbb2 tyrosine kinase receptor (HER2) TT6EO5L ERBB2_HUMAN Not Available [1]
Tumor associated calcium signal transducer 2 (TACSTD2) TTP2HE5 TACD2_HUMAN Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Aggressive cancer
ICD Disease Classification 2A00-2F9Z
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Erbb2 tyrosine kinase receptor (HER2) DTT ERBB2 5.67E-03 -1.26 -2.05
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of Biocytogen